Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes [NA]
A clinical trial update assesses the safety, tolerability, and effectiveness of duodenal mucosal RF vapor ablation as a potential method to …
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Weight Loss Clinical Decision Support [NA]
This entry notes an active-not-recruiting clinical trial on Weight Loss Clinical Decision Support sponsored by HealthPartners Institute, stu…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: New T-UP: Engaging Vulnerable Students in Diabetes Prevention [NA]
A UCLA-led clinical trial is currently recruiting to test a diabetes prevention program aimed at vulnerable students with prediabetes or Typ…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus [NA]
This clinical trial update describes retreatment with radiofrequency vapor ablation of the duodenal mucosa for adults with type 2 diabetes w…
-
CLINICAL_TRIALS withdrawal · 2025-11-06Clinical Trial Update: Detection of Diffuse Scar in Patients With Diabetes [Phase 4]
A Phase 4 clinical trial examining detection of diffuse scar in patients with Type 2 diabetes mellitus has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Implementing WHO HEARTS-D Guidelines in Bangladesh for Diabetes Control and Prevention [NA]
A clinical trial in Bangladesh to implement WHO HEARTS-D guidelines for type 2 diabetes control and prevention, sponsored by Florida Interna…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Family Model Diabetes Self-Management Education in Faith Based Organizations [NA]
This clinical trial update reports the completion of a study evaluating a family-based diabetes self-management education program delivered …
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Gut Microbiota in Metabolic Surgery
A Vanderbilt University Medical Center-led clinical trial is examining how gut microbiota changes relate to metabolic surgery and associated…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Decision Support for Detection of Chronic Kidney Disease in Type II Diabetes Mellitus [NA]
Completed clinical trial at Brigham and Women's Hospital evaluating decision-support tools to detect chronic kidney disease in individuals w…
-
FDA approval · 2025-11-03FDA Approved: LINAGLIPTIN AND METFORMIN HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application for a generic fixed-dose combination of linagliptin and metformin hydrochloride (Novadoz Pharmaceutica…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Addressing Disparities in Diabetes Care [NA]
A completed clinical trial update addressing disparities in diabetes care.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) [Phase 3]
Phase 3 pediatric study of ertugliflozin for Type 2 Diabetes Mellitus has completed, and results have been posted.
-
EMA approval · 2025-10-31EMA Authorised: Januvia (sitagliptin) — Merck Sharp and Dohme B.V
EMA has authorized Januvia (sitagliptin) for type 2 diabetes mellitus. Merck Sharp & Dohme B.V. is the marketing authorization holder.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
A completed trial comparing tirzepatide to sitagliptin in adults with type 2 diabetes and cardiovascular risk evaluates comparative effectiv…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM [Phase 4]
Phase 4 trial evaluating the efficacy of a fixed-dose combination of dapagliflozin/metformin versus separately administered dapagliflozin an…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity [EARLY_Phase 1]
This ClinicalTrials.gov entry reports an EARLY Phase 1 study of phentermine/topiramate in adolescents with Type 2 diabetes and obesity, spon…
-
EMA approval · 2025-10-30EMA Authorised: Ristaben (sitagliptin) — Merck Sharp & Dohme B.V.
The EMA authorised Ristaben, a sitagliptin product by Merck Sharp & Dohme B.V., for treatment of type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction [EARLY_Phase 1]
A Phase 1 study conducted by the Medical College of Wisconsin to explore how autophagy influences microvascular dysfunction in type 2 diabet…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Healthy Living Anson Study [NA]
Clinical trial update for the Healthy Living Anson study from UNC Chapel Hill, currently recruiting to evaluate interventions for obesity an…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Implementation of Team Clinic for Type 2 Diabetes (TCT2) [NA]
This document is a clinical trial update describing the implementation of Team Clinic for Type 2 Diabetes at Children's Hospital Los Angeles…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Designing Team Clinic for Youth With Type 2 Diabetes
This clinical trial update covers the design of a Team Clinic for youth with Type 2 diabetes, sponsored by Children’s Hospital Los Angeles, …
-
CLINICAL_TRIALS other · 2025-10-28Clinical Trial Update: A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia [Phase 3]
A Phase 3 clinical trial evaluating BGM0504 for Type 2 diabetes in Indonesia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot Study [NA]
A completed pilot study from the University of Hawaii analyzed the efficacy and feasibility of the PILI Lifestyle Program combined with soci…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
This ClinicalTrials.gov entry describes a mixed-methods study examining health-related social needs among African American adults with chron…
-
FDA label_change · 2025-10-24FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLYXAMBI (empagliflozin and linagliptin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.…